Chongqing Zhifei Biological Products: Investor Relations Activity Record Form
Chongqing Zhifei Biological Products: Announcement on the pledge of some of the shares of the controlling shareholder of the company
Chongqing Zhifei Biological Products: Announcement on the approval notice for clinical trials of the 26-valent pneumococcal conjugate vaccine
Zhifei Biotech: Announcement on changing the registered capital and amending the company's articles of association
Zhifei Biotech: Supervisory Board Decision Announcement
Zhifei Biotech: Report of the Audit Committee of the Company's Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Zhifei Biotech: Announcement on holding an online briefing on the 2023 annual results
Zhifei Biotech: 2023 Annual Report Summary
Zhifei Biotech: Announcement on changing the names of employee representatives and supervisors
Zhifei Biotech: Independent Director Mr. Chen Xujiang's 2023 Debriefing Report
Zhifei Biotech: Independent Director Mr. Gong Tao's 2023 Debriefing Report
Zhifei Biotech: Report for the first quarter of 2024
Zhifei Biotech: Notice on holding the 2023 Annual General Meeting of Shareholders
Zhifei Biotech: 2023 Internal Control Verification Report
Zhifei Biotech: Announcement on Renewal of the Company's 2024 Audit Institution
Zhifei Biotech: 2023 Zhifei Biotech Social Responsibility Report
Zhifei Biotech: Announcement of Board Resolutions
Zhifei Biotech: Independent Director Ms. Yuan Lin's 2023 Debriefing Report
Zhifei Biotech: 2023 Annual Audit Report
Zhifei Biotech: 2024-24 Announcement on the 2023 Profit Distribution Plan and 2024 Mid-Term Dividend Proposal
No Data